Dale Broadrick - 08 Feb 2024 Form 4 Insider Report for BioRestorative Therapies, Inc. (BRTX)

Reporting relationship: 10%+ Owner
Issuer ticker: BRTX
Reported as of: 08 Feb 2024
Net transaction value: +$206,023
SEC form: 4
Accepted by SEC: 12 Feb 2024, 09:26:34 UTC
Prior SEC filing: 09 Feb 2024
Next SEC filing: 05 Nov 2024
Source filing: View source filing
Reporting owner signature: /s/ Dale Broadrick

Filing notes and source

Key filing fact

Dale Broadrick filed Form 4 for BioRestorative Therapies, Inc. (BRTX) on 12 Feb 2024.

Key facts

This page summarizes Dale Broadrick's Form 4 filing for BioRestorative Therapies, Inc. (BRTX).
2 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 12 Feb 2024, 09:26.

Change

Previous filing in this sequence was filed on 09 Feb 2024.
Current net transaction value: +$206,023.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BRTX transaction

Common Stock

Purchase

Transaction value: $92,449
Shares: +73,959
Change %: +23%
Price: $1.25
Shares after: 391,931
Date: 08 Feb 2024
Ownership: Ssee Footnote
Footnotes: F1

BRTX transaction

Common Stock

Purchase

Transaction value: $113,574
Shares: +86,041
Change %: +22%
Price: $1.32
Shares after: 477,972
Date: 09 Feb 2024
Ownership: See Footnote
Footnotes: F1

BRTX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 447,045
Date: 08 Feb 2024
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BRTX holding Derivative

Warrant to acquire Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 250
Date: 08 Feb 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 250
Exercise price: $120.00

BRTX holding Derivative

Warrant to acquire Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 276
Date: 08 Feb 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 276
Exercise price: $120.00

BRTX holding Derivative

Warrant to acquire Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 833
Date: 08 Feb 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 833
Exercise price: $120.00

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Owned by Fleetco, Inc. of which the reporting person is a 93% shareholder.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .